BTK Inhibitors for Chronic Lymphocytic Leukemia: Pharmacist Viewpoints

Join us for a CPE-certified live social media event, providing instant engagement with top pharmacy experts in chronic lymphocytic leukemia (CLL) management. The event will include two expert oncology pharmacists as they provide their perspectives on Bruton tyrosine kinase (BTK) inhibitors in the CLL treatment landscape and pharmacy best practices around their use. Attendees will be able to interact directly with the speakers.
- - - - -

Faculty: Jenna R. Ciervo, PharmD, BCOP
Faculty: Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC
- - - - -

Earn free 0.50 Knowledge-based ACPE (0.050 CEUs). Access for credit will be shared at the end of this live event.

Click the link to view the Accreditation and Disclosure details before participating: Medscape.org/viewarticle/1001556


Supported by an independent educational grant from BeiGene.